These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16283420)

  • 1. Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.
    Matsui T; Shimada K; Tohma S
    Clin Rheumatol; 2006 Jul; 25(4):610-1. PubMed ID: 16283420
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance?
    Caterbi S; Bistoni O; Alunno A; Bartoloni E; Gerli R
    J Rheumatol; 2015 Jun; 42(6):1063-4. PubMed ID: 26034235
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis.
    Son JJ; Ishimori M; Mirocha J; Weisman MH; Forbess LJ
    Medicine (Baltimore); 2021 Apr; 100(16):e25558. PubMed ID: 33879708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
    Jansen TL; Bruyn GA
    J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
    Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
    Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of the anti-CCP assay: experiences with 700 patients.
    Sauerland U; Becker H; Seidel M; Schotte H; Willeke P; Schorat A; Schlüter B; Domschke W; Gaubitz M
    Ann N Y Acad Sci; 2005 Jun; 1050():314-8. PubMed ID: 16014547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting studies of diagnostic accuracy.
    McIsaac MA
    J Rheumatol; 2014 Dec; 41(12):2340-2. PubMed ID: 25452177
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
    Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
    Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Roubenoff R; Beckman E; Weinblatt M; Shadick N; Gregersen PK
    Ann Intern Med; 2008 Mar; 148(5):403; author reply 403-4. PubMed ID: 18316760
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Arkfeld DG
    Ann Intern Med; 2008 Mar; 148(5):403; author reply 403-4. PubMed ID: 18316759
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.
    Suwannalai P; Trouw LA; Toes RE; Huizinga TW
    Mod Rheumatol; 2012 Feb; 22(1):15-20. PubMed ID: 21732051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.
    Ji L; Li G; Xu Y; Zhou W; Zhang Z
    Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Sghiri R; Bouagina E; Zaglaoui H; Mestiri H; Harzallah L; Harrabi I; Ghannouchi M; Mokhtar F; Ghedira I
    Rheumatol Int; 2007 Oct; 27(12):1125-30. PubMed ID: 17447069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis.
    Sun J; Zhang Y; Liu L; Liu G
    Clin Exp Rheumatol; 2014; 32(1):11-21. PubMed ID: 24050751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis.
    Pinheiro GC; Scheinberg MA; Aparecida da Silva M; Maciel S
    Ann Intern Med; 2003 Aug; 139(3):234-5. PubMed ID: 12899598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.